February 11, 2015
Spellman DS et al. Prot Clin Appl 2015;9:715-731.
Development and Evaluation of a Multiplexed Mass Spectrometry-Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF
You might also be interested by
Brochures & Infographics
High Performance Technologies for Cytokine Measurement
July 29, 2024
Immune Monitoring
More infoWebcasts & Webinars
Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions
May 2, 2023
Proteomics/Mass Spectrometry
More info